Denmark· DK-28105368014
Nexgard Spectra
A milbemycin oxime, combinations product containing afoxolaner, milbemycinoxim, registered in Denmark by Boehringer Ingelheim Vetmedica GmbH. The same ATC class is registered in 2 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Afoxolaner, milbemycinoxim is registered in 2 of 19 countries.
Countries holding a registration under ATC QP54AB51 (milbemycin oxime, combinations), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 1 of them publish a price we can compare per daily dose
Afoxolaner, milbemycinoxim · ATC QP54AB51
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- afoxolaner, Milbemycinoxim
- Manufacturer
- Boehringer Ingelheim Vetmedica GmbH
- Country
- Denmark (DK)
- ATC code
- QP54AB51
- ATC class
- milbemycin oxime, combinations
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105368014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QP54AB51
Milbemycin oxime, combinations, as other registers publish it.
- FinlandAlpramil VetAlfasan Nederland B.V.
- FinlandAlpramil VetAlfasan Nederland B.V.
- FinlandAlpramil VetAlfasan Nederland B.V.
- FinlandAlpramil VetAlfasan Nederland B.V.
- FinlandAlpramil VetAlfasan Nederland B.V.
- FinlandAlpramil VetAlfasan Nederland B.V.
- DenmarkAlpramil Vet.Alfasan Nederland BV
- DenmarkAlpramil Vet.Alfasan Nederland BV
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d34a0d93-0c48-4038-bdb8-684afa19f665 GET /v1/drugs/d34a0d93-0c48-4038-bdb8-684afa19f665?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tyggetabletter",
"source": "dkma",
"strength": "38 mg + 8 mg",
"auth_role": "MOD",
"dk_drugid": "28105368014",
"substance": "afoxolaner, Milbemycinoxim",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42019"
}See everything about afoxolaner, milbemycinoxim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.